Answers are grounded in this paper and cite their sources.
This letter highlights a major discrepancy between North American and European guidelines regarding the routine use of beta-blockers in asymptomatic patients with reduced LVEF.
We read with interest the comparison between the different Guidelines on chronic heart failure (CHF).1 In the article, the discrepancies and possible explanations are discussed. However, an important disagreement between the experts, which is likely to affect patient's management is not reported.1 In the Guidelines of the ACC/AHA, beta-blockers are recommended for all patients without a history of MI who have a reduced left ventricular ejection fraction (LVEF) with no HF symptoms (Level of recommendation I, Level of Evidence C).2 Moreover, beta-blockers are recommended for all stable patients with current or prior symptoms of HF and reduced LVEF. (Level of recommendation I, Level of Evidence A).2 In the Guidelines of the HFSA the combination of a beta-blocker and an ACE-inhibitor is recommended as routine therapy for asymptomatic patients with an LVEF <40%. (Post-MI: Strength of Evidence B; non-post-MI: Strength of Evidence C).3 According to the ESC Guidelines, beta-blockers should be considered for the treatment of all patients (in NYHA class II–IV) (Class of recommendation I, Level of Evidence A).4 However, in patients with LV systolic dysfunction, without symptomatic heart failure beta-blockade is recommended only after an acute myocardial infarction to reduce mortality (Class of recommendation I, Level of Evidence B), but not in patients with dilated cardiomyopathy.4 Although controlled clinical trials are lacking in the use of beta-blockers in patients with a low EF and no symptoms,5,6 it would be important for the clinician to know that expert consensus is not different in Europe and North America. In conclusion, the authors are right that ‘the greatest remaining question is why we need four guidelines, including three from North America’.7
No takes yet. Share an insight, caveat, or question.
Filippatos et al. (2007) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: